Science and Research

Impact of SEBiotic™ on Human Gut

Bacillus coagulans LBSC demonstrated stability in acidic and gastrointestinal conditions, remained viable with various foods, and positively modulated gut microbiota in IBS patients by enhancing beneficial bacterial phyla and restoring gut microenvironment balance.

Efficacy and Safety of SEBiotic™ for IBS

Study evaluating safety and efficacy of Bacillus coagulans LBSC [DSM17654] in irritable bowel syndrome (IBS) through a prospective, interventional, randomized, double-blind, and placebo-controlled, CONSORT compliant clinical trial.

Efficacy and Safety of SEBiotic™ in Treatment of Acute Diarrhea with Abdominal Discomfort

A prospective, interventional, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Bacillus coagulans LBSC in the treatment of acute diarrhea with abdominal discomfort.

Process and Storage of SEBiotic™ in Food Matrices

In the present study, Bacillus coagulansLBSC DSM 17654, a probiotic strain, was incorporated into various foods to assess its stability during processing and storage and ability to decrease food calorie contents.

Genome-Based Safety Assessment for SEBiotic™ for Probiotic Application

Study on Bacillus coagulans strain LBSC (DSM 17654) describes the use of whole genome sequencing, in correlation with the phenotypic properties to assess the safety of the strain.

Spore-forming Bacillus coagulans LBSC can withstand high pressure processing (HPP), a popular technological method used in the food industry

Study reports the viability of Bacillus coagulans LBSC [DSM 17654] spores at high hydrostatic pressures processing.